Detalhe da pesquisa
1.
Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Nature
; 566(7742): E1, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30659290
2.
Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer.
Cancer
; 129(2): 215-225, 2023 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36397290
3.
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer.
N Engl J Med
; 382(6): 514-524, 2020 02 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31826360
4.
Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects.
Small
; 19(12): e2205961, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36587987
5.
Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting.
BMC Cancer
; 23(1): 112, 2023 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-36721174
6.
Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy.
Eur J Appl Physiol
; 123(7): 1567-1581, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36939876
7.
Development of skeletal muscle atrophy and intermuscular adipose tissue in patients with early breast cancer treated with chemotherapy.
Am J Physiol Cell Physiol
; 323(4): C1325-C1332, 2022 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36094434
8.
Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 Patients.
Ann Surg Oncol
; 29(5): 3322-3334, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-34994906
9.
Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Nature
; 534(7605): 47-54, 2016 06 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27135926
10.
Incidental axillary dose delivery to axillary lymph node levels I-III by different techniques of whole-breast irradiation: a systematic literature review.
Strahlenther Onkol
; 197(9): 820-828, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34292348
11.
Impact of COVID-19 and lockdown regarding blood transfusion.
Transfusion
; 61(8): 2327-2335, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34255374
12.
Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice.
Qual Life Res
; 30(11): 3255-3266, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-33387291
13.
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
Lancet
; 393(10191): 2591-2598, 2019 06 29.
Artigo
Inglês
| MEDLINE | ID: mdl-31178155
14.
Pembrolizumab in the Treatment of Breast Cancer.
N Engl J Med
; 387(3): 273-274, 2022 07 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35857664
15.
Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis.
Breast Cancer Res Treat
; 180(3): 597-609, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32100144
16.
Fulvestrant and palbociclib combination in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer patients.
Breast Cancer Res Treat
; 179(2): 371-376, 2020 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-31612291
17.
Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2- advanced breast cancer in five European countries.
BMC Cancer
; 20(1): 855, 2020 Sep 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32894087
18.
Persistent taxane-induced neuropathy in elderly patients treated for localized breast cancer.
Breast J
; 26(12): 2376-2382, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33307596
19.
Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
Cancer
; 125(22): 3974-3984, 2019 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31318460
20.
Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics.
Breast Cancer Res Treat
; 177(2): 383-393, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31172407